ALCJ · Crossject SA
1.34
EURUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Euro80.03M
PE
10.80
EV/EBITDA
7.1
DIV Yield
0%
Payout Ratio
0%
MQV Rating
4Weak
As at 21/09/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- HALO 200
- HALO All
- HALO Balance Sheet
- HALO Capital Efficiency
- HALO Consensus Value
- HALO GARP
- HALO Small
- HALO Value
Key Fundamentals
EPS 3 yr Growth
-33.50%
EBITDA Margin
N/A
Operating Cashflow
-€6m
Free Cash Flow Return
-57.10%
ROIC
-93.30%
Interest Coverage
-4.90
Quick Ratio
1.10
Performance
52 weeks range
Low 1.19 - 2.69
Trade Value (12mth)
US$161,645.00
1 week
-3.91%
1 month
-6.09%
YTD
-38.18%
1 year
-20.6%
All time high
12.68
Additional Data
Shares Outstanding (Fully Diluted)
52m
HALO Sector
Healthcare
Next Company Report Date
31-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
EUR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Weak
Garp
Very Strong
Mqv Small
Weak
Momentum
Price
Very Weak
Earnings
Weak
Growth
Earnings
Strong
Dividends
Very Weak
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Gemmes Venture SA | Private Company |
| Government of France | Government |
| Crossject SA | Public Company |
